Serum CP is typically decreased in patients with Wilson’s Disease (WD) [27], and other conditions characterized by marked renal or enteric protein loss, including during severe end-stage liver disease of any etiology and in some rare neurologic diseases [28]. This evidence concerns the gene CP and Wilson disease.